AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, H.
Right arrow Articles by Yoshimoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, H.
Right arrow Articles by Yoshimoto, T.

ARTICLE

Correlation between Choline Level Measured by Proton MR Spectroscopy and Ki-67 Labeling Index in Gliomas

Hiroaki Shimizu,a, Toshihiro Kumabea, Reizo Shiranea and Takashi Yoshimotoa

a From the Department of Neurosurgery, Kohnan Hospital (H.S.); and the Department of Neurosurgery, Tohoku University School of Medicine (T.K., R.S., T.Y.), Sendai, Japan.

BACKGROUND AND PURPOSE: The clinical relevance of proton MR spectroscopy needs further clarification as to its usefulness and limitations. The purpose of this study was to investigate the correlation between the semiquantitative choline-containing compound level (Cho value) measured by MR spectroscopy and the Ki-67 labeling index in gliomas.

METHODS: Localized proton spectra were obtained in 26 consecutive patients with glioma who subsequently underwent surgery for tumor removal. Metabolic values in the spectra were measured semiquantitatively using an external standard of reference. The Ki-67 labeling index was measured in the surgical specimen. Because the semiquantitative metabolic values may be affected by tissue components included in the spectroscopic voxel, the MR imaging appearance of the voxel within the tumor was classed as homogeneous or heterogeneous through visual evaluation of the presence of necrosis, cyst, hemorrhage, and calcification, and pattern of enhancement.

RESULTS: We found a strong linear correlation between the Cho value and the Ki-67 labeling index in the 18 homogeneous gliomas, but no correlation was found in the eight heterogeneous gliomas, which turned out to be malignant.

CONCLUSION: The semiquantitative Cho value is a reliable predictor of proliferative activity of gliomas when the tumor appears homogeneous on MR images.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
P.H. Lai, H.H. Weng, C.Y. Chen, S.S. Hsu, S. Ding, C.W. Ko, J.H. Fu, H.L. Liang, and K.H. Chen
In Vivo Differentiation of Aerobic Brain Abscesses and Necrotic Glioblastomas Multiforme Using Proton MR Spectroscopic Imaging
AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
A. Panigrahy, M. D. Nelson Jr, J. L. Finlay, R. Sposto, M. D. Krieger, F. H. Gilles, and S. Bluml
Metabolism of diffuse intrinsic brainstem gliomas in children
Neuro-oncol, February 1, 2008; 10(1): 32 - 44.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Weber, S. Zoubaa, M. Schlieter, E. Juttler, H. B. Huttner, K. Geletneky, C. Ittrich, M. P. Lichy, A. Kroll, J. Debus, et al.
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors
Neurology, June 27, 2006; 66(12): 1899 - 1906.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. G. Astrakas, D. Zurakowski, A. A. Tzika, M. K. Zarifi, D. C. Anthony, U. De Girolami, N. J. Tarbell, and P. M. Black
Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors
Clin. Cancer Res., December 15, 2004; 10(24): 8220 - 8228.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
K. E. Warren
NMR Spectroscopy and Pediatric Brain Tumors
Oncologist, June 1, 2004; 9(3): 312 - 318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag
Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. L. Zakian, S. Eberhardt, H. Hricak, A. Shukla-Dave, S. Kleinman, M. Muruganandham, K. Sircar, M. W. Kattan, V. E. Reuter, P. T. Scardino, et al.
Transition Zone Prostate Cancer: Metabolic Characteristics at H MR Spectroscopic Imaging--Initial Results
Radiology, October 1, 2003; 229(1): 241 - 247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N. Bulakbasi, M. Kocaoglu, F. Ors, C. Tayfun, and T. Ucoz
Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors
AJNR Am. J. Neuroradiol., February 1, 2003; 24(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. A. Tzika, M. K. Zarifi, L. Goumnerova, L. G. Astrakas, D. Zurakowski, T. Young-Poussaint, D. C. Anthony, R. M. Scott, and P. McL. Black
Neuroimaging in Pediatric Brain Tumors: Gd-DTPA-enhanced, Hemodynamic, and Diffusion MR Imaging Compared with MR Spectroscopic Imaging
AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 322 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
L. A. Kwock
Tuning in on Tumor Activity with Proton MR Spectroscopy
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 807 - 808.
[Full Text]


Home page
RadiologyHome page
S. Cha, E. A. Knopp, G. Johnson, S. G. Wetzel, A. W. Litt, and D. Zagzag
Intracranial Mass Lesions: Dynamic Contrast-enhanced Susceptibility-weighted Echo-planar Perfusion MR Imaging
Radiology, April 1, 2002; 223(1): 11 - 29.
[Abstract] [Full Text] [PDF]